Logo image of BBH

VANECK BIOTECH ETF (BBH) Stock Price, Quote, News and Overview

NASDAQ:BBH - Nasdaq - US92189F7261 - ETF - Currency: USD

147.9  +1.54 (+1.05%)

Fundamental Rating

4

BBH gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 81 industry peers in the Automobile Components industry. Both the profitability and the financial health of BBH get a neutral evaluation. Nothing too spectacular is happening here. While showing a medium growth rate, BBH is valued expensive at the moment. BBH also has an excellent dividend rating. These ratings would make BBH suitable for dividend investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

BBH had positive earnings in the past year.
In the past year BBH had a positive cash flow from operations.
In the past 5 years BBH has always been profitable.
In the past 5 years BBH always reported a positive cash flow from operatings.
BBH Yearly Net Income VS EBIT VS OCF VS FCFBBH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

1.2 Ratios

BBH has a Return On Assets (5.04%) which is in line with its industry peers.
BBH has a Return On Equity (10.12%) which is in line with its industry peers.
BBH has a Return On Invested Capital (8.53%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for BBH is in line with the industry average of 8.88%.
Industry RankSector Rank
ROA 5.04%
ROE 10.12%
ROIC 8.53%
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.12%
ROIC(5y)8.42%
BBH Yearly ROA, ROE, ROICBBH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 6.93%, BBH is in line with its industry, outperforming 48.15% of the companies in the same industry.
BBH's Profit Margin has been stable in the last couple of years.
The Operating Margin of BBH (11.72%) is comparable to the rest of the industry.
BBH's Operating Margin has been stable in the last couple of years.
The Gross Margin of BBH (28.49%) is comparable to the rest of the industry.
BBH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 11.72%
PM (TTM) 6.93%
GM 28.49%
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
BBH Yearly Profit, Operating, Gross MarginsBBH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

5

2. Health

2.1 Basic Checks

BBH has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
BBH has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, BBH has less shares outstanding
BBH has a worse debt/assets ratio than last year.
BBH Yearly Shares OutstandingBBH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BBH Yearly Total Debt VS Total AssetsBBH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

BBH has an Altman-Z score of 4.71. This indicates that BBH is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of BBH (4.71) is better than 88.89% of its industry peers.
BBH has a debt to FCF ratio of 3.74. This is a good value and a sign of high solvency as BBH would need 3.74 years to pay back of all of its debts.
With a Debt to FCF ratio value of 3.74, BBH perfoms like the industry average, outperforming 46.91% of the companies in the same industry.
BBH has a Debt/Equity ratio of 0.35. This is a healthy value indicating a solid balance between debt and equity.
BBH's Debt to Equity ratio of 0.35 is on the low side compared to the rest of the industry. BBH is outperformed by 61.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 3.74
Altman-Z 4.71
ROIC/WACC1.11
WACC7.66%
BBH Yearly LT Debt VS Equity VS FCFBBH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

A Current Ratio of 1.76 indicates that BBH should not have too much problems paying its short term obligations.
BBH's Current ratio of 1.76 is on the low side compared to the rest of the industry. BBH is outperformed by 74.07% of its industry peers.
BBH has a Quick Ratio of 1.11. This is a normal value and indicates that BBH is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.11, BBH is doing worse than 72.84% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.11
BBH Yearly Current Assets VS Current LiabilitesBBH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

More info and screens

4

3. Growth

3.1 Past

BBH shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.42%.
BBH shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.64% yearly.
Looking at the last year, BBH shows a decrease in Revenue. The Revenue has decreased by -4.06% in the last year.
Measured over the past years, BBH shows a small growth in Revenue. The Revenue has been growing by 2.41% on average per year.
EPS 1Y (TTM)-5.42%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-5.56%
Revenue 1Y (TTM)-4.06%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.87%

3.2 Future

The Earnings Per Share is expected to grow by 17.51% on average over the next years. This is quite good.
Based on estimates for the next years, BBH will show a small growth in Revenue. The Revenue will grow by 3.22% on average per year.
EPS Next Y35.36%
EPS Next 2Y23.07%
EPS Next 3Y17.51%
EPS Next 5YN/A
Revenue Next Year3.42%
Revenue Next 2Y3.38%
Revenue Next 3Y3.54%
Revenue Next 5Y3.22%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BBH Yearly Revenue VS EstimatesBBH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B
BBH Yearly EPS VS EstimatesBBH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 49.14, the valuation of BBH can be described as expensive.
BBH's Price/Earnings ratio is a bit more expensive when compared to the industry. BBH is more expensive than 77.78% of the companies in the same industry.
When comparing the Price/Earnings ratio of BBH to the average of the S&P500 Index (28.64), we can say BBH is valued expensively.
BBH is valuated quite expensively with a Price/Forward Earnings ratio of 36.34.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BBH indicates a slightly more expensive valuation: BBH is more expensive than 74.07% of the companies listed in the same industry.
BBH's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.44.
Industry RankSector Rank
PE 49.14
Fwd PE 36.34
BBH Price Earnings VS Forward Price EarningsBBH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

BBH's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. BBH is more expensive than 80.25% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BBH is valued a bit more expensive than the industry average as 76.54% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 42.23
EV/EBITDA 17.86
BBH Per share dataBBH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
BBH's earnings are expected to grow with 17.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.39
PEG (5Y)29.91
EPS Next 2Y23.07%
EPS Next 3Y17.51%

More info and screens

8

5. Dividend

5.1 Amount

BBH has a Yearly Dividend Yield of 4.57%, which is a nice return.
BBH's Dividend Yield is rather good when compared to the industry average which is at 4.67. BBH pays more dividend than 92.59% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.52, BBH pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.57%

5.2 History

On average, the dividend of BBH grows each year by 7.84%, which is quite nice.
BBH has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)7.84%
Div Incr Years0
Div Non Decr Years0
BBH Yearly Dividends per shareBBH Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8 1

5.3 Sustainability

51.01% of the earnings are spent on dividend by BBH. This is a bit on the high side, but may be sustainable.
The dividend of BBH is growing, but earnings are growing more, so the dividend growth is sustainable.
DP51.01%
EPS Next 2Y23.07%
EPS Next 3Y17.51%
BBH Yearly Income VS Free CF VS DividendBBH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B
BBH Dividend Payout.BBH Dividend Payout, showing the Payout Ratio.BBH Dividend Payout.PayoutRetained Earnings

More info and screens

VANECK BIOTECH ETF

NASDAQ:BBH (4/23/2025, 8:00:01 PM)

147.9

+1.54 (+1.05%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)02-12 2025-02-12/amc
Earnings (Next)04-24 2025-04-24
Inst Owners39.74%
Inst Owner Change0.57%
Ins Owners0%
Ins Owner ChangeN/A
Market Cap104.38B
Analysts78.4
Price Target186.27 (25.94%)
Short Float %0%
Short Ratio1.21
Dividend
Industry RankSector Rank
Dividend Yield 4.57%
Yearly Dividend1.54
Dividend Growth(5Y)7.84%
DP51.01%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.53%
PT rev (3m)0.9%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.1%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 49.14
Fwd PE 36.34
P/S 3.34
P/FCF 42.23
P/OCF 20.98
P/B 4.88
P/tB 6.65
EV/EBITDA 17.86
EPS(TTM)3.01
EY2.04%
EPS(NY)4.07
Fwd EY2.75%
FCF(TTM)3.5
FCFY2.37%
OCF(TTM)7.05
OCFY4.77%
SpS44.22
BVpS30.29
TBVpS22.24
PEG (NY)1.39
PEG (5Y)29.91
Profitability
Industry RankSector Rank
ROA 5.04%
ROE 10.12%
ROCE 11.13%
ROIC 8.53%
ROICexc 10.06%
ROICexgc 12.57%
OM 11.72%
PM (TTM) 6.93%
GM 28.49%
FCFM 7.92%
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.12%
ROIC(5y)8.42%
ROICexc(3y)10.2%
ROICexc(5y)9.71%
ROICexgc(3y)12.52%
ROICexgc(5y)11.97%
ROCE(3y)11.87%
ROCE(5y)10.97%
ROICexcg growth 3Y-2.77%
ROICexcg growth 5Y-0.41%
ROICexc growth 3Y-3.05%
ROICexc growth 5Y-0.34%
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
F-Score5
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 3.74
Debt/EBITDA 1.25
Cap/Depr 110.04%
Cap/Sales 8.02%
Interest Coverage 12.7
Cash Conversion 83.87%
Profit Quality 114.33%
Current Ratio 1.76
Quick Ratio 1.11
Altman-Z 4.71
F-Score5
WACC7.66%
ROIC/WACC1.11
Cap/Depr(3y)113.8%
Cap/Depr(5y)101.88%
Cap/Sales(3y)7.8%
Cap/Sales(5y)7.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.42%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-5.56%
EPS Next Y35.36%
EPS Next 2Y23.07%
EPS Next 3Y17.51%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.06%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.87%
Revenue Next Year3.42%
Revenue Next 2Y3.38%
Revenue Next 3Y3.54%
Revenue Next 5Y3.22%
EBIT growth 1Y-7.52%
EBIT growth 3Y1.98%
EBIT growth 5Y1.14%
EBIT Next Year70.46%
EBIT Next 3Y24.51%
EBIT Next 5Y17.57%
FCF growth 1Y-29.4%
FCF growth 3Y21.5%
FCF growth 5Y7.22%
OCF growth 1Y-17.99%
OCF growth 3Y14.27%
OCF growth 5Y5.48%